(Q40487166)

21 September 2017

1 reference

title

Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (English)

1 reference

21 September 2017

1 reference

2

R N Brogden

1 reference

21 September 2017

H M Bryson

1

1 reference

21 September 2017

publication date

1 April 1993

1 reference

21 September 2017

1 reference

21 September 2017

volume

45

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

589-621

1 reference

Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses

21 September 2017

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Study of finding the optimum dose of cefetamet pivoxil in complicated urinary tract infections

1 reference

12 December 2020

Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children

1 reference

12 December 2020

In vitro activity of RO 15-8074 and RO 19-5247

1 reference

12 December 2020

Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency

1 reference

12 December 2020

The pharmacokinetics of new oral cephalosporins in children

1 reference

12 December 2020

Clinical experience with 1000 patients treated with cefetamet pivoxil

1 reference

12 December 2020

In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.

1 reference

12 December 2020

Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074)

1 reference

12 December 2020

Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa

1 reference

12 December 2020

MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin

1 reference

12 December 2020

Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.

1 reference

12 December 2020

Problems in evaluation of adverse reactions to beta-lactam antibiotics.

1 reference

12 December 2020

In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.

1 reference

12 December 2020

The clinical evaluation of antibacterial drugs: guidelines of the British Society for Antimicrobial Chemotherapy

1 reference

12 December 2020

Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil

1 reference

12 December 2020

Susceptibility of new beta-lactams to the expanded-spectrum beta-lactamase CTX-1.

1 reference

12 December 2020

Considerations in dosage selection for third generation cephalosporins

1 reference

12 December 2020

Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.

1 reference

12 December 2020

Effects of cefetamet (Ro 15-8074) on Treponema pallidum and experimental syphilis

1 reference

12 December 2020

Different doses of cefetamet pivoxil (Ro 15-8075) in the treatment of acute uncomplicated gonococcal urethritis in men

1 reference

12 December 2020

Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review

1 reference

12 December 2020

Clinical pharmacokinetics of the third generation cephalosporins

1 reference

12 December 2020

In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases

1 reference

12 December 2020

In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi

1 reference

12 December 2020

Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin

1 reference

12 December 2020

Efficacy and tolerability of cefetamet pivoxil in diabetic patients with urinary tract infections: a case-control study

1 reference

12 December 2020

In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.

1 reference

12 December 2020

Carnitine deficiency induced by pivampicillin and pivmecillinam therapy

1 reference

12 December 2020

The pharmacokinetics of ceftibuten in humans

1 reference

12 December 2020

Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae

1 reference

12 December 2020

Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil

1 reference

12 December 2020

In vitro activity of cefetamet (Ro 15-8074)

1 reference

12 December 2020

Cefetamet pivoxil in paediatric patients suffering from lower respiratory tract infections

1 reference

12 December 2020

Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics

1 reference

12 December 2020

In vitro activity of new antibiotics against Haemophilus influenzae.

1 reference

12 December 2020

Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Cefetamet pivoxil: bacteriostatic and bactericidal activity of the free acid against 355 gram-negative rods

1 reference

12 December 2020

Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis

1 reference

12 December 2020

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

12 December 2020

In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef

1 reference

12 December 2020

The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment

1 reference

12 December 2020

Cefetamet in the treatment of acute sinusitis in adult patients

1 reference

12 December 2020

Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

1 reference

12 December 2020

Cefetamet pivoxil in community-acquired pneumonia: an overview

1 reference

12 December 2020

Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes.

1 reference

12 December 2020

In-vitro activity of Ro-15-8074, a new oral cephalosporin

1 reference

12 December 2020

Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans

1 reference

12 December 2020

Oral cephalosporins in perspective

1 reference

12 December 2020

In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).

1 reference

12 December 2020

The in-vitro activity of cefdinir (FK482), a new oral cephalosporin

1 reference

12 December 2020

MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin

1 reference

12 December 2020

Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil

1 reference

12 December 2020

Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy

1 reference

12 December 2020

Branhamella catarrhalis: beta-lactamase production and sensitivity to oral antibiotics, including new cephalosporins

1 reference

12 December 2020

Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects

1 reference

12 December 2020

A new plasmidic cefotaximase from patients infected withSalmonella typhimurium

1 reference

12 December 2020

Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria

1 reference

12 December 2020

Studies on orally active cephalosporin esters. II. Chemical stability of pivaloyloxymethyl esters in phosphate buffer solution

1 reference

12 December 2020

Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers

1 reference

12 December 2020

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins

1 reference

12 December 2020

Determination of cefetamet and its orally active ester, cefetamet pivoxyl, in biological fluids by high-performance liquid chromatography

1 reference

12 December 2020

Effectiveness of cefetamet pivoxil in the treatment of pyelonephritis in children

1 reference

12 December 2020

Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

12 December 2020

In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae

1 reference

12 December 2020

Cefetamet pivoxil in acute pyelonephritis: an open study.

1 reference

12 December 2020

Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991

1 reference

12 December 2020

Cefetamet pivoxil in pediatric otitis media

1 reference

12 December 2020

Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests

1 reference

12 December 2020

Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates

1 reference

12 December 2020

Treatment of respiratory tract infections with cephalosporin antibiotics

1 reference

12 December 2020

Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis

1 reference

12 December 2020

Cefpodoxime: comparable evaluation with other orally available cephalosporins. With a note on the role of beta-lactamases

1 reference

12 December 2020

[Epidemiologic and therapeutic study on gonococcal infections--clinical efficacy of cefetamet pivoxil]

1 reference

12 December 2020

In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites

1 reference

12 December 2020

In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin

1 reference

12 December 2020

Mechanisms of Bacterial Resistance to Antimicrobial Agents, with Particular Reference to Cefotaxime and Other β-Lactam Compounds

1 reference

12 December 2020

In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins

1 reference

12 December 2020

In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis

1 reference

12 December 2020

In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae

1 reference

12 December 2020

Comparative study of cefetamet pivoxil and penicillin V in the treatment of group A beta-hemolytic streptococcal pharyngitis

1 reference

12 December 2020

Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers

1 reference

12 December 2020

10.2165/00003495-199345040-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1047742041

0 references

1 reference